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ABSTRACT 
8-Aminoquinoline (8AQ) derivatives have been reported to have antimalarial, anticancer, and antioxi-
dant activities. This study investigated the potency of 8AQ-5-substituted (iodo and nitro) uracils metal 
(Mn, Cu, Ni) complexes (1-6) as antimalarial and antimicrobial agents. Interestingly, all of these metal 
complexes (1-6) showed fair antimalarial activities. Moreover, Cu complexes 2 (8AQ-Cu-5Iu) and 5 
(8AQ-Cu-5Nu) exerted antimicrobial activities against Gram-negative bacteria including P. shigel-
loides and S. dysenteriae. The results reveal application of 8AQ and its metal complexes as potential 
compounds to be further developed as novel antimalarial and antibacterial agents. 
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INTRODUCTION 
Aminoquinoline, a class of heterocyclic 
scaffold with an amino group, is frequently 
found in diverse bioactive compounds. Ami-
noquinoline derivatives have a variety of 
pharmacological properties including anti-
malarial, antileishmanial (Kulshrestha et al., 
2011), antitrypanosomal (Yardley et al., 
2010), anticancer, antibacterial (Jain et al., 
2005; Kaur et al., 2007), and antifungal 
(Kaur et al., 2011) activities, as well as metal 
chelator (Nguyen et al., 2015). 8-Amino-
quinolines, the first group of synthetic com-
pounds, have been synthesized for antimalar-
ial activity.  
Primaquine, 8-aminoquinoline (8AQ) 
analog, is approved by the Food and Drug 
Administration (FDA) for the treatment of 
relapses in Plasmodium infections (Hill et 
EXCLI Journal 2016;15:144-152 – ISSN 1611-2156 
Received: December 24, 2015, accepted: January 28, 2016, published: February 18, 2016 
 
 
145 
al., 2006). It exhibits antimalarial activity 
against P. vivax, P. ovale and P. falciparum 
(White et al., 2014). In addition, tafenoquine 
is the 8AQ drug being developed for P. vivax 
that is currently in clinical trials (Nasveld et 
al., 2010). However, the usage of these 8-
aminoquinolines is limited because they are 
likely to cause red blood cell hemolysis in 
patients with glucose-6-phosphate dehydro-
genase (G6PD) deficiency (Bolchoz et al., 
2001). Regarding safety treatment and pre-
vention of hemolytic anemia, patients with 
malarial infection should be screened for 
G6PD deficiency before treating with these 
medicines. Moreover, 8-aminoquinolines 
(sitamaquine and NPC1161) have been 
shown to be active against Leishmania and 
Trypanosoma parasites (Kulshrestha et al., 
2011; Yardley et al., 2010). Thus, searching 
for novel potential bioactive compounds is 
required for the treatment of malaria-infected 
patients. These drugs/compounds (Figure 1) 
are 8-AQ derivatives in which their 8-NH2 
groups are substituted with various alkyla-
mines side chain (Yardley et al., 2010; Jain 
et al., 2005; Kaur et al., 2007) including bis 
(8-AQs) (Kaur et al., 2011). 
Metal ions play important roles in many 
biological processes in living organisms. 
Metal complexes constitute a central metal 
atom surrounded by ligands (Cox, 2005), 
showing significant progress in treatment of 
human diseases including cancer, leukemia, 
infection and inflammation (Rafique et al., 
2010). Metal complexes have been reported 
to deliver ligands as drugs to target sites, 
leading to reduce side effects and improve 
pharmacokinetics. Recently, metal complex-
es of 8-hydroxyquinoline (8HQ) have been 
shown to be antiviral, antiparasitic, antioxi-
dant, antiinflammatory, and antidiabetic 
agents (Prachayasittikul et al., 2013). Quino-
line-based compounds have high selectivity 
of human malaria due to their metal bind-
ing/chelating abilities and lipophilicities to 
penetrate cell membranes to reach the target 
sites of action (Scheibel and Adler, 1982, 
1980, 1981) . 
 
 
 
 
Figure 1: Chemical structures of primaquine, tafenoquine, sitamaquine and NPC1161 
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The activation by redox active metal 
ions, Cu(II), Fe(III), and Zn(II), was ob-
served in patient’s brains with Alzheimer’s 
disease (AD) (Nguyen et al., 2014). These 
metal ions can bind strongly with beta amy-
loid in amyloid plaques which cause oxida-
tive stress, reactive oxygen species (ROS) 
and beta-amyloid toxicity (Nguyen et al., 
2015). Additionally, the excess of copper as-
sociated with abnormal tau phosphorylation 
in the brain can induce neuronal inflamma-
tion and death. Tetradentate ligands, clio-
quinol and 8AQ are known as metal ion che-
lators, which can transport copper within 
metal deficient neurons for the treatment of 
AD (Ceccom et al., 2012). One of bis (8-
aminoquinoline) ligands, PA1637, has high 
selectivity for copper (II) chelation used in a 
model of non-transgenic mice injected with 
Ab1-42 oligomer via an intracerebroventric-
ular area. It can prevent the memory loss in 
the mouse model (Nguyen et al., 2014). 
Recent reports have demonstrated that 
chemical structure modifications of 8AQ 
mostly improve antimalarial activity 
(Kannan et al., 2015; Miranda et al., 2014) 
and decrease toxicity (Kaur et al., 2012). 
Additionally, transition metal complexes of 
mixed ligands 8AQ-uracil derivatives (5-
iodo and 5-nitro) have been reported to dis-
play their antioxidative and cytotoxic activi-
ties by our group (Pingaew et al., 2013). 
Various drugs and bioactive compounds 
such as 8HQ have been found to exert anti-
cancer and antimalarial activities (Prachaya-
sittikul et al., 2013). Malaria parasites, P. 
falciparum, exhibit rapid nucleic acid syn-
thesis during their intraerythrocytic growth 
phase which requires robust supplies of pu-
rine and pyrimidine in the metabolic path-
ways (Cassera et al., 2011). Orotic acid is the 
only preformed pyrimidine utilized by ma-
larial parasite (Rathod et al., 1992). 5-
Fluoroorotate, pyrimidine derivative, is rec-
ognized to have antimalarial activity against 
P. falciparum with IC50 < 10 nM (Cassera et 
al., 2011). Other pyrimidine derivatives such 
as uracil and 5-fluorouracil have been re-
ported to show weak inhibition of P. falcipa-
rum with IC50 range of 5-10 µM (Cassera et 
al., 2011). Thus, a combination of 8AQ and 
uracils (5-iodouracil and 5-nitrouracil) in the 
one molecule as metal-based compounds 
may provide the compounds with enhanced 
antimalarial activity. Here, the potential of 
metal complexes of 8AQ-5-substituted ura-
cils as antimalarial and antimicrobial agents 
has been reported. 
 
MATERIALS AND METHODS 
Tested compounds 
8AQ metal (Mn, Cu, Ni) complexes (1-6, 
Figure 2a) were synthesized and confirmed 
by spectral data by our group (Pingaew et al., 
2013). Chemical structures of free ligands 
8AQ, 5-iodouracil (5Iu), and 5-nitrouracil 
(5Nu) are shown in Figure 2b. 
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Figure 2: Chemical structures of (a) 8AQ-5Iu (or 5Nu) metal complexes and (b) ligands 
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Parasite strain and in vitro culture 
P. falciparum (K1 strain), chloroquine 
resistance, was maintained following the 
previous method (Trager and Jensen, 1976). 
P. falciparum was cultured in RPMI-1640 
medium containing 25 mM of HEPES, 10 % 
of human serum, and 40 mg/L of gentamicin. 
Sorbitol was used to synchronize P. falcipa-
rum before starting the assay following the 
previous method to gain ring stage of malar-
ia (Lambros and Vanderberg, 1979). To 
avoid sorbitol effect, the culture was incu-
bated for 48 h before treatment with the 
compounds. 
 
Antimalarial assay  
Antimalarial activities of the tested com-
pounds (1-6 and ligands) were investigated 
based on the rate of P. falciparum growth via 
microscopic technique using methanol-fixed 
Giemsa stain. The ring stage-infected RBCs 
were diluted with fresh uninfected RBCs and 
complete medium to obtain a final concen-
tration at 2 % parasitemia. The parasite sus-
pension was put onto a 96-well microtiter 
plate, then the microtiter plate was added 
with different final concentrations of each 
compound as follows: 0.01, 0.1, 1, 10, 100 
and 1000 µg/mL compared to a reference 
drug; artesunate 0.2 ng/mL (IC50). The rate 
of P. falciparum growth was observed for 
4 days, and each concentration was per-
formed in triplicate. The efficacies of the 
compounds were evaluated by determining 
the concentration that reduced the growth of 
parasite by 50 % (IC50). 
 
Antimicrobial testing  
Method of agar dilution was performed 
to study the antimicrobial activity as former-
ly described (Prachayasittikul et al., 2011). 
All compounds were dissolved in dimethyl 
sulfoxide (DMSO), and were separately 
mixed with 1 mL of Mueller Hinton (MH) 
broth. Then, the final concentrations of 32-
256 µg/mL were carried out by transferring 
the mixture to the MH agar, and the negative 
control was MH broth. The cell concentra-
tion of microbes used in this study was ad-
justed to 108 cells/mL in 0.9 % normal saline 
after the microbes were cultured at 37 °C for 
24 h in the MH broth. The inhibitions of mi-
crobial growth were detected in each com-
pound following the inoculation onto the 
MH agar, and incubation at 37 °C for 24 h. 
Twenty-four bacteria and two yeasts were 
tested as listed in Table 1.  
 
RESULTS AND DISCUSSION 
Antimalarial activity  
The synthesized 8AQ metal complexes 
(1-6) and free ligands were tested against 
chloroquine-resistant P. falciparum (K1) us-
ing artesunate as a reference drug. It was 
found that all of the metal complexes 
showed fair antimalarial activity with IC50 
100-1000 µg/mL (Table 2). Similarly, the 
free ligands (8AQ, 5Iu and 5Nu) of such 
metal complexes exhibited antimalarial ac-
tivity with the same IC50 values. To date, the 
antimalarial activity of these metal complex-
es (1-6) as well as 8AQ, 5Iu and 5Nu has not 
been reported in the literature. Quinoline-
based compounds are potent chelators hav-
ing high lipophilic property. The antimalarial 
activity of these compounds was exhibited 
by inhibiting the growth of parasites and 
glycolysis process due to the inactivation of 
various enzymes including metalloprotein 
oxidase (Scheibel and Adler, 1980). The an-
timalarial activity of 8AQ may be derived 
from its formation of quinoneimine metabo-
lite which ultimately generates hydrogen 
peroxides and oxidative stress in erythro-
cytes (Shiraki et al., 2011). It is reasonable to 
suggest that the dissociation of lipophilic 
8AQ-metal complexes (1-6) could give rise 
to charged complexes (8AQ-M)+/ or 
(5Iu/5Nu-M)+, and free ligands (8AQ, 5Iu 
and 5Nu) (Pingaew et al., 2013) in which the 
8AQ chelator can interact with parasitic en-
zyme in different ways such as interacting 
with SH or NH2 group, and with certain met-
al ion of the enzyme leading to the growth 
inhibition of P. falciparum (Owens, 1953). 
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Table 1: Twenty-six microorganisms used in antimicrobial testing 
Groups of microbes Microbial strains 
Yeasts Candida albicans ATCC 90028 Saccharomyces cerevisiae ATCC 2601 
Gram-positive bacteria 
Bacillus cereus 
Listeria monocytogenes 
Corynebacterium diphtheriae NCTC 10356 
Micrococcus luteus ATCC 10240 
Bacillus subtilis ATCC 6633 
Staphylococcus epidermidis ATCC 12228 
Enterococcus faecalis ATCC 33186 
Enterococcus faecalis ATCC 29212 
Staphylococcus aureus ATCC 29213 
Staphylococcus aureus ATCC 25923 
Gram-negative bacteria
Aeromonas hydrophila 
Morganella morganii 
Plesiomonas shigelloides 
Citrobacter freundii 
Shigella dysenteriae 
Salmonella enteritidis 
Achromobacter xylosoxidans ATCC 2706 
Pseudomonas stutzeri ATCC 17587 
Shewanella putrefaciens ATCC 8071 
Pseudomonas aeruginosa ATCC 15442 
Salmonella typhimurium ATCC 13311 
Klebsiella pneumoniae ATCC 700603 
Escherichia coli ATCC 25922 
Serratia macescens ATCC 8100 
 
Table 2: Antimalarial activity of metal complexes 
(1-6) and ligands 
Compounda IC50b (µg/mL)
8AQ-Mn-5Iu (1) 100-1000 
8AQ-Cu-5Iu (2) 100-1000 
8AQ-Ni-5Iu (3) 100-1000 
8AQ-Mn-5Nu (4) 100-1000 
8AQ-Cu-5Nu (5) 100-1000 
8AQ-Ni-5Nu (6) 100-1000 
8AQ 100-1000 
5Iu 100-1000 
5Nu 100-1000 
a Artesunate was used as a reference drug. 
b IC50: For the synthesized compound; fair activity is 100-
1000 (µg/mL); good activity is 10 - <100 (µg/mL). 
 
 
As the aforementioned that orotic acid 
(uracil-6-carboxylic acid) is required for in-
traerythrocytic growth of P. falciparum 
(Rathod et al., 1992). Orotic acid derivative, 
5-fluoroorotate, has been reported to show 
antimalarial activity against the P. falcipa-
rum (Cassera et al., 2011). In addition, uracil 
and 5-fluorouracil displayed weak antimalar-
ial activity (Cassera et al., 2011). In this re-
gard, antimalarial activity of 5Iu and 5Nu 
may be possibly involved in the pyrimidine 
metabolic pathway of malaria parasite 
(Rathod et al., 1992). Another plausible ex-
planation may be due to the electron donor 
property of 5Iu and 5Nu (Pingaew et al., 
2013) that could interact with certain metal 
ions of the parasitic enzyme (Owens, 1953).  
 
Antimicrobial activity  
The agar dilution method (Prachayasit-
tikul et al., 2011) was performed to deter-
mine the activity of 8AQ metal complexes 
(1-6), 5Iu, 5Nu, and 8AQ, as antimicrobial 
agents against twenty-six microbes. DMSO 
was used as a control. The results revealed 
that only Cu-complexes 2 and 5 inhibited the 
growth of Gram-negative bacteria (Table 3), 
and the DMSO showed no effect toward the 
tested microorganisms. The Cu-complex 5 
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Table 3: Antimicrobial activity of metal complex-
es (1-6) and ligands 
Compounda Microorganism MIC
b 
(µg/mL) 
8AQ-Mn-5Iu (1)c - - 
8AQ-Cu-5Iu (2)d - - 
8AQ-Ni-5Iu (3)c - - 
8AQ-Mn-5Nu 
(4)c - - 
8AQ-Cu-5Nu (5)e P. shigelloides 256
8AQ-Ni-5Nu (6)c - - 
8AQc - - 
5Iuc - - 
5Nuc - - 
a A 10 µg/mL of ampicillin (control) exhibited complete inhibi-
tion to S. aureus ATCC 25923, S. aureus ATCC 29213, S. 
epidermidis ATCC 12228, S. typhimurium ATCC 13311, B. 
subtilis ATCC 6633, C. diphtheriae NCTC 10356, L. Mono-
cytogenes, M. luteus ATCC 10240, P. Shigelloides, P. stut-
zeri ATCC 17587.  
b Minimum concentration that inhibits the growth of microor-
ganisms. 
c The compound showed no growth inhibition against the 
tested microorganisms.  
d At 256 µg/mL, compound 2 showed 25 % inhibition against 
P. shigelloides and S. dysenteriae. 
e At 128 µg/mL and 64 µg/mL, compound 5 showed 75 % 
and 25 % inhibition against P. shigelloides, respectively. 
 
 
exhibited antigrowth activity against P. Shi-
gelloides with MIC value of 256 µg/mL. In 
addition, the P. shigelloides was partially in-
hibited by compound 5 at 128 µg/mL and 64 
µg/mL showing 75 % and 25 % inhibition, 
respectively. The Cu-complex 2 at 256 
µg/mL exerted 25 % inhibition against P. 
shigelloides and S. dysenteriae. Other metal 
complexes (1, 3, 4 and 6) were found to be 
inactive antimicrobials. It should be noted 
that the free ligands (8AQ, 5Iu and 5Nu) 
displayed no antimicrobial activity. This 
might be suggested that the lipophilic prop-
erty of Cu-complexes 2 and 5 deriving from 
complexation of mixed ligands, 8AQ-5Iu 
and 8AQ-5Nu, could enhance absorption of 
compounds to their target sites of action. It 
was observed that the metal complex 5 
showed better antimicrobial activity as com-
pared to the complex 2. It could be reasona-
bly explained that the higher electron with-
drawing group (5-nitro) of 5Nu ligand facili-
tated the better dissociation of the complex 5 
to give charged complex (8AQ-Cu)+ and free 
ligand (5Nu) comparing to the complex 2 
with lower electron withdrawing group (5-
iodo). The charged complex (8AQ-Cu)+ will 
interact and block the metal binding on the 
enzyme accounting for antimicrobial activity 
of the metal complexes (Anjaneyulu et al., 
1982; Srisung et al., 2013).  
P. shigelloides is a Gram-negative bacte-
rium commonly found in fresh and brackish 
water (Farmer et al., 2006), soil and animals 
such as fish, oyster, mussel, prawn and crab 
as well as in human (Khardori and Fainstein, 
1988). P. shigelloides is an opportunistic 
pathogen which is associated with gastroen-
teritis (Mandal et al., 1982; McNeeley et al., 
1984; Schubert and Holz-Bremer, 1999; 
Stock, 2004). This bacterium is considered 
as one of the important causes of traveler’s 
diarrhea (Schubert and Holz-Bremer, 1999). 
Moreover, it was reported to cause ex-
traintestinal infection with high fatality rate 
such as bacteremia, meningitis, and pseudo-
appendicitis (Billiet et al., 1989; Brenden et 
al., 1988; Fischer et al., 1988; Lee et al., 
1996). P. shigelloides has been found to re-
sist to several antimicrobial drugs including 
penicillin, vancomycin, tetracycline and ery-
thromycin, especially cabapenems, fluoro-
quinolones, trimethoprim and cotrimoxazole 
(trimethoprim-sulpha-methoxazole) (Rama-
livhana and Obi, 2009). 
 
CONCLUSION 
Oxidative stress is involved in the patho-
physiology of malarial infection. It is well 
recognized that Plasmodium parasites digest 
hemoglobin resulting in the production of 
heme which triggers the generation of reac-
tive oxygen species, and can lead to anemia 
and death. Thus, compounds with antioxi-
dant activity may alleviate the progression of 
malarial infection, and possibly prevent the 
sequelae. In this study, 8-aminoquinoline 
metal complexes become an interesting class 
of bioactive compounds as antimalarial 
against P. falciparum, and antimicrobial 
against Gram-negative bacteria. Moreover, 
these metal complexes (8AQ-5-substituted 
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uracils) are more effective antimicrobials 
than 8AQ.  
It can be concluded that 8- aminoquino-
line and its metal complexes show a wide 
range of antimalarial and antimicrobial activ-
ities. Therefore, further investigation will be 
explored to understand and to achieve the 
compounds with improved activities.  
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